Communication of the meeting of Transparency Council No. 2/2026 on 19 January 2026 with resolutions
We invite you to read minutes of the meeting of Transparency Council No. 2/2026 on 19 January 2026 during which the following resolutions were adopted:
- At its meeting on 19 January 2026, the Transparency Council adopted position No. 2/2026 on the validity of classifying the healthcare service “ABI – ankle-brachial index measurement – non-invasive examination.”
- At its meeting on 19 January 2026, the Transparency Council adopted position No. 3/2026 on the evaluation of Coatoris (ezetimibe + atorvastatin) in multiple indications
- At its meeting on 19 January 2026, the Transparency Council adopted position No. 4/2026 on the evaluation of Keytruda (pembrolizumab) under drug program B.58 “Treatment of patients with esophageal and gastroesophageal junction cancer (ICD-10: C15-C16)”
- At its meeting on 19 January 2026, the Transparency Council adopted position No. 5/2026 on the validity of issuing approvals for the reimbursement of Quviviq for the indication: non-organic insomnia
- At its meeting on 19 January 2026, the Transparency Council adopted opinion No. 5/2026 on the draft health policy program “Support for women in Wrocław during menopause: MENOPAUSE – health, satisfaction, maturity!” (City of Wrocław)
- At its meeting on 19 January 2026, the Transparency Council adopted opinion No. 6/2026 on the draft program “Health Policy Program for pertussis vaccination for adults in the Piaseczno County for the years 2026-2028.”
- At its meeting on 19 January 2026, the Transparency Council adopted opinion No. 7/2026 on the draft program “Prevention and rehabilitation of posture defects in students in grades I-IV of primary schools (usually aged 7-10) in the Siechnice Municipality in 2026-2027.”
- At its meeting on 19 January 2026, the Transparency Council adopted opinion No. 8/2026 on the draft program “Program for the prevention of shingles and postherpetic neuralgia in the population aged 55 and over” (Opole)